Here we describe the cases of two elite athletes, with a diagnosis of Arrhythmogenic Cardiomyopathy (ACM), in which a Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) has been implanted. Both patients experienced a ventricular tachycardia during exercise and received effective S-ICD shocks that interrupted arrhythmias. This report reveals for the first time that the S-ICD is effective in reverting arrhythmias in ACM patients, even during exercise. Moreover, these cases may confirm that competition/physical activity is associated with ICD shocks. This article is protected by copyright. All rights reserved.
Catto V, Dessanai MA, Sommariva E, Tondo C, Russo AD. S-ICD is effective in preventing sudden death in Arrhythmogenic Cardiomyopathy athletes during exercise. Pacing Clin Electrophysiol 2019 Apr 20. doi: 10.1111/pace.13702. [Epub ahead of print]